Our entire company is passionate about living our mission every day, and this is an exciting opportunity to accelerate access to the latest technology at the point of patient care, for vaccine development, and other direct pandemic response efforts.
WAUKESHA, Wis. (PRWEB) October 12, 2020
Dedicated Computing is expediting development of two embedded computing products that support one of the world’s premier in-vitro diagnostic companies in their fight against COVID-19. Upon development completion, Dedicated is accelerating the deployment of these products, which are at the core of the manufacturer’s immunoassay and clinical chemistry analyzers. These analyzers are deployed to over 130 countries worldwide, including over 2,000 patient testing facilities throughout the U.S. Funding for this solution was provided in part by Intel Corporation’s Pandemic Response Technology Initiative.
Testing labs are pushing hard to increase their volume based on the COVID-19 demand from the public. Dedicated and Intel are supporting this increase by deploying the most up-to-date technology available, as quickly as possible. These systems run up to 440 tests per hour, accommodating 25+ million tests per month.
“We are committed more than ever to our mission of Powering the World’s Most Important Devices®,” says Don Schlidt, President and CEO of Dedicated Computing. “Our entire company is passionate about living our mission every day, and this is an exciting opportunity to accelerate access to the latest technology at the point of patient care, for vaccine development, and other direct pandemic response efforts.”
About Dedicated Computing
Dedicated Computing’s mission is Powering the World’s Most Important Devices®. As an Original Design Manufacturer (ODM) of proprietary, advanced computing systems, Dedicated Computing serves global Original Equipment Manufacturers (OEMs) in the Healthcare, Life Sciences, Military & Commercial, and Industrial Automation markets. To learn more, visit Dedicated Computing.